What is Electromedical Technologies?
Headquartered in Scottsdale, Arizona, Electromedical Technologies, Inc. is a commercial-stage company specializing in bioelectronic medical devices. With FDA clearance, the company initially focused on providing relief for chronic, acute, intractable, and post-operative pain conditions. Through academic collaborations, Electromedical Technologies is actively developing a research program to explore the effects of electro-modulation on the human body, investigating impacts on cell signaling, virus assembly, and immune responses. The ultimate goal is to enhance overall human wellbeing by reducing pain and improving health outcomes.
How much funding has Electromedical Technologies raised?
Electromedical Technologies has raised a total of $2M across 2 funding rounds:
Other Financing Round
$1M
Private Equity
$1M
Other Financing Round (2020): $1M, investors not publicly disclosed
Private Equity (2021): $1M led by Yorkville Advisors Global
Key Investors in Electromedical Technologies
Yorkville Advisors Global
Yorkville Advisors Global is an investor participating in the funding round. Further details on their specific investment focus are not publicly available.
What's next for Electromedical Technologies?
The recent major strategic investment positions Electromedical Technologies for accelerated growth and expanded research capabilities. This capital infusion is expected to fuel the development of its bioelectronic medical device pipeline and deepen its understanding of electro-modulation's therapeutic potential. The company's focus on university collaborations suggests a commitment to evidence-based innovation, aiming to translate scientific discoveries into tangible improvements in patient care and pain management. Future developments will likely involve further clinical validation and market expansion for its FDA-cleared products.
See full Electromedical Technologies company page
